Dasha Afanasieva

Stay informed with Dasha Afanasieva’s coverage and analysis for Fortune.

NEW YORK, NEW YORK – DECEMBER 04: Ken Griffin, Founder and C.E.O. of Citadel speaks during the New York Times annual DealBook summit at Jazz at Lincoln Center on December 04, 2024 in New York City. The NYT summit with Andrew Ross Sorkin returns with interviews on the main stage including Sam Altman, co-founder and C.E.O. of OpenAI, Jeff Bezos, founder and executive chairman of Amazon and owner of the Washington Post, former U.S. President Bill Clinton and Prince Harry, The Duke of Sussex, among others. The discussions will touch topics such as business, politics and culture. (Photo by Michael M. Santiago/Getty Images)

Ken Griffin calls tariffs a ‘huge’ mistake hurting middle class

By Dasha Afanasieva and Bloomberg

A woman is shopping at a supermarket in Bogor, West Java, Indonesia, on March 3, 2024. The statistics bureau reports that the monthly inflation rate has accelerated to 2.75%, compared with 2.57% in January. Indonesia’s February inflation rate is surpassing forecasts due to surging food prices. (Photo by Adriana Adie/NurPhoto via Getty Images)

Unilever’s woes in Indonesia carry a warning for its new CEO

By Claire Jiao, Dasha Afanasieva, and others

Ben and Jerry's cofounders Jerry Greenfield and Ben Cohen

Ben & Jerry’s founders discuss buying back ice cream brand

By Liana Baker, Dasha Afanasieva, and others

Tubs of Ben and Jerry’s ice cream, manufactured by Unilever Plc, in a freezer at an Iceland Foods Ltd. supermarket in Christchurch, UK, on Wednesday, June 15, 2022. “Britain’s cost-of-living crisis — on track to big the biggest squeeze since the mid-70s — will continue to worsen before it starts to ease at some point next year,” said Jack Leslie, senior economist at the Resolution Foundation, a research group campaigning against poverty. Photographer: Chris Ratcliffe/Bloomberg via Getty Images

Ben & Jerry’s sues parent Unilever for muzzling it over Gaza

By Dasha Afanasieva and Bloomberg

Hein Schumacher, chief executive officer of Unilever Plc, following an interview at the company’s office in London, UK, on Thursday, April 18, 2024. Unilever plans to abandon or water down a string of environmental and social pledges against the backdrop of a growing backlash from investors, consumers and politicians against companies pursuing non-financial objectives. Photographer: Vivian Wan/Bloomberg via Getty Images

Unilever sales growth accelerates under CEO’s overhaul plan

By Dasha Afanasieva and Bloomberg

Mark Schneider, chief executive officer of Nestle SA, gestures as he speaks during a panel session at the 61st Global Summit of the Consumer Goods Forum (CGF) in Berlin, Germany, on Thursday, June 22, 2017. The summit runs June 20-23. Photographer: Rolf Schulten/Bloomberg via Getty Images

Nestle ‘still in repairing mode’ warns CEO Mark Schneider, as Swiss giant lowers sales outlook and seeks to lure cost-conscious customers back

By Dasha Afanasieva and Bloomberg

Nestle's CEO Ulf Mark Schneider looks on during a general shareholders meeting of Swiss food giant Nestle in Ecublens, near Lausanne, on April 18, 2024. (Photo by Fabrice COFFRINI / AFP) (Photo by FABRICE COFFRINI/AFP via Getty Images)

Swiss giant Nestle has rolled back recycling targets and the difference amounts to the weight of 30 Eiffel Towers

By Dasha Afanasieva and Bloomberg

MADRID, SPAIN – NOVEMBER 02: A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. The company’s revenues rose by 38% to DKK 58.73 billion, some 7.8 billion euros. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug. (Photo By Ricardo Rubio/Europa Press via Getty Images)

Danone and Nestle search for a way around Ozempic Revolution with high protein yogurt and vitamins against hair-loss

By Dasha Afanasieva, Deena Shanker, and others

CEO of the Danone group Antoine de Saint-Affrique.

Danone, like Swiss competitor Nestle, is doubling down on foods for an aging population

By Dasha Afanasieva and Bloomberg

Vladimir Putin, eating ice cream

Unilever to continue making ‘Soviet-style’ ice creams in Russia as it spins off the division elsewhere

By Dasha Afanasieva and Bloomberg

Nestle's CEO Ulf Mark Schneider

Swiss giant Nestle hit by slowing sales, unlike rivals Unilever and Danone who reported a surge

By Dasha Afanasieva and Bloomberg

SWITZERLAND – NOVEMBER 17: Nestle’S Nescafe on display in a supermarket in Biel, Switzerland, on Monday, Nov. 17, 2008. Nestle SA, the maker of Perrier bottled water and Nesquik chocolate milk, reported a second straight quarter of sales declines after higher prices led consumers to seek cheaper alternatives. (Photo by Adrian Moser/Bloomberg via Getty Images)

Nestle made big gains when high inflation gave it a reason to charge consumers more. But as prices level, the Nespresso maker says growth is set to cool

By Dasha Afanasieva and Bloomberg

Scotland salmon

‘You also end up with the salmon being squeezed’: Scotland’s top food export reels from 53 million excess deaths over last 5 years

By Dasha Afanasieva, Stephen Treloar, and others

Close up of baby formula Aptamil in a grocery store.

Danone will cut baby formula prices by 7% after U.K. antitrust watchdog probe into prices that rose 25% in 2 years

By Dasha Afanasieva and Bloomberg

LOS ANGELES, CALIFORNIA – APRIL 17: In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes- who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. (Photo illustration by Mario Tama/Getty Images)

Fast-food outlets ‘are going to be hurt’ in areas where Ozempic and Wegovy are heavily used, but the selloff in candy and beer stocks is ‘somewhat overdone’

By Lisa Pham, Dasha Afanasieva, and others